Namwiwat Medical PCLBKK:NAM -1.73%40 Net Margin % is 3.22% as of Mar. 2026, which is 80% below its 10-year median of 16.23. GuruFocus rates BKK:NAM with a GF Score™ of 40/100 and a GF Value™ of ฿6.04 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Namwiwat Medical PCL ranks better than 56% on this metric.
The historical rank and industry rank for Namwiwat Medical PCL's Net Margin % or its related term are showing as below:
BKK:NAM'
s Net Margin % Range Over the Past 10 Years
Min: 4.54 Med: 16.23 Max: 18.24
Current: 4.54
BKK:NAM's Net Margin % is ranked better than 56% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs BKK:NAM: 4.54
Namwiwat Medical PCL (BKK:NAM) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Namwiwat Medical PCL Net Margin % Related Terms
Namwiwat Medical PCL Net Margin % Historical Data
* Premium members only.
The historical data trend for Namwiwat Medical PCL's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Namwiwat Medical PCL's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Namwiwat Medical PCL Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Namwiwat Medical PCL's Net Margin % distribution charts can be found below:
* The bar in red indicates where Namwiwat Medical PCL's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Namwiwat Medical PCL (BKK:NAM) has a Net Margin % of 3.22% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Namwiwat Medical PCL and its competitors. This is 80% below median its historical median of 16.23. Over the past decade, Namwiwat Medical PCL's Net Margin % has ranged from 4.54 to 18.24. According to the industry distribution chart, Namwiwat Medical PCL ranks #359 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 44%.
Is Namwiwat Medical PCL's Net Margin % too high?
Namwiwat Medical PCL's current Net Margin % of 3.22% is 80% below median its 10-year median of 16.23. Over the past 10 years, this metric has ranged from a low of 4.54 to a high of 18.24. The Medical Devices & Instruments industry median Net Margin % is 2.06. Namwiwat Medical PCL's value of 3.22% is 56.3% above this industry median. Based on the distribution chart, Namwiwat Medical PCL ranks #359 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Namwiwat Medical PCL has a GF Score™ of 40/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Namwiwat Medical PCL's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Namwiwat Medical PCL ranks #359 out of 816 companies for Net Margin %. This puts Namwiwat Medical PCL in the upper half of its industry. The industry median Net Margin % is 2.06. Namwiwat Medical PCL's value of 3.22% is 56.3% above this benchmark. Historically, Namwiwat Medical PCL's own Net Margin % has ranged from 4.54 to 18.24 over the past decade. While the company's 10-year median is 16.23 vs. the industry median of 2.06, Namwiwat Medical PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.06, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Namwiwat Medical PCL's current Net Margin % of 3.22% is 56.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Namwiwat Medical PCL and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Namwiwat Medical PCL's current Net Margin % is 3.22%, which is 80% below median its own 10-year median of 16.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Namwiwat Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Namwiwat Medical PCL (BKK:NAM) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿6.04, compared to a current price of ฿3.40 — trading 43.7% below its estimated fair value. The current Net Margin % is 3.22%, which is 80% below median its 10-year median of 16.23 and 56.3% above the Medical Devices & Instruments industry median of 2.06. Namwiwat Medical PCL's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Namwiwat Medical PCL (BKK:NAM), the current Net Margin % is 3.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Namwiwat Medical PCL (BKK:NAM) Overvalued in 2026?
Based on GuruFocus' analysis, Namwiwat Medical PCL stock appears to be undervalued.
The current stock price of ฿3.40 is trading 43.7% below its estimated GF Value™ of ฿6.04.
GuruFocus considers Namwiwat Medical PCL to be Significantly Undervalued.
Key valuation signals for BKK:NAM:
Net Margin %: 3.22% (80% below median its 10-year median of 16.23)
GF Value™: ฿6.04 vs. price of ฿3.40 (43.7% below fair value)
Industry Position: 56.3% above the Medical Devices & Instruments median (#359 of 816)
No single metric tells the full story. See the BKK:NAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Namwiwat Medical Corp PCL operates a manufacturing business, importing and distributing Medical tools and equipment for cleaning and disinfecting medical equipment in hospitals and nursing homes in accordance with public health standards. The Group has a total of three reporting segments as follows: Medical equipment manufacturing and distribution segment; Medical supplies manufacturing and distribution segment; CSSD disinfection Medical equipment maintenance services segment, and waste services segment. The Group operates its business in one geography, only in Thailand.
40GF Score
Get the complete analysis for BKK:NAM
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:NAM has been successfully added to your 
